Original language | English |
---|---|
Pages (from-to) | 269-275 |
Number of pages | 7 |
Journal | Ocular Surface |
Volume | 15 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2017 Jul |
ASJC Scopus subject areas
- Ophthalmology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
TFOS DEWS II Introduction. / Nelson, J. Daniel; Craig, Jennifer P.; Akpek, Esen K.; Azar, Dimitri T.; Belmonte, Carlos; Bron, Anthony J.; Clayton, Janine A.; Dogru, Murat; Dua, Harminder S.; Foulks, Gary N.; Gomes, José A.P.; Hammitt, Katherine M.; Holopainen, Juha; Jones, Lyndon; Joo, Choun Ki; Liu, Zuguo; Nichols, Jason J.; Nichols, Kelly K.; Novack, Gary D.; Sangwan, Virender; Stapleton, Fiona; Tomlinson, Alan; Tsubota, Kazuo; Willcox, Mark D.P.; Wolffsohn, James S.; Sullivan, David A.
In: Ocular Surface, Vol. 15, No. 3, 07.2017, p. 269-275.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - TFOS DEWS II Introduction
AU - Nelson, J. Daniel
AU - Craig, Jennifer P.
AU - Akpek, Esen K.
AU - Azar, Dimitri T.
AU - Belmonte, Carlos
AU - Bron, Anthony J.
AU - Clayton, Janine A.
AU - Dogru, Murat
AU - Dua, Harminder S.
AU - Foulks, Gary N.
AU - Gomes, José A.P.
AU - Hammitt, Katherine M.
AU - Holopainen, Juha
AU - Jones, Lyndon
AU - Joo, Choun Ki
AU - Liu, Zuguo
AU - Nichols, Jason J.
AU - Nichols, Kelly K.
AU - Novack, Gary D.
AU - Sangwan, Virender
AU - Stapleton, Fiona
AU - Tomlinson, Alan
AU - Tsubota, Kazuo
AU - Willcox, Mark D.P.
AU - Wolffsohn, James S.
AU - Sullivan, David A.
N1 - Funding Information: The TFOS DEWS II workshop participants thank Amy Gallant Sullivan (TFOS Executive Director, USA) for raising the funds that made this Workshop possible; Amy and Rose M. Sullivan (TFOS Operations Manager, USA) for their help in the organization of this Workshop; and Stephanie Wong (University of Waterloo, Canada) for her technical assistance. The TFOS DEWS II was supported by unrestricted donations from Alcon, Novartis , Shire , Allergan , Bausch+Lomb , Akorn , CooperVision , Dompé , Horus Pharma , Lμbris Biopharma , Oculeve , TearLab , Laboratoires Théa , SIFI , Sun Pharma , Johnson & Johnson Vision Care , Carl Zeiss Meditec , Quint Health , Scope Ophthalmics and Senju . Funding Information: J. D. Nelson, Chair: TearSolutions (I, C, R), Santen (F, C), Editor in Chief, Ocular Surface (F). J. P. Craig, Vice Chair: Allergan (Oculeve), Manuka Health NZ (F), E-Swin, CooperVision, Alcon, Optima Pharmaceuticals, OPSM NZ, Akorn, Optimed, Medmont (R); Carl Zeiss Meditec, Eye Institute Auckland (C). D. A. Sullivan, Organizer: Allergan, Cempra, GlaxoSmithKline, Novagali/Santen, TearLab, (F); Singularis (I); M.G. Therapeutics (C); Dompé, Fovea, Laboratoire Théa, Lμbris Sanofi/Novartis, (R). E. Akpek: Allergan (F); Biogen, Seattle Genetics, GSK, Nicox (C). D. Azar: Novartis/Alcon, Google. Chicago Medical Society (F); Novartis, Google, (I); University of Illinois (E); Alcon/Google (C); Novartis/Alcon/Google (R). C. Belmonte: Avizorex Pharma, (F) (I) (C) (P) (R); Coopervision (F). A. J. Bron: Allergan, DiagnosTear, TearLab, Reckitt Benckiser (C); Allergan (R); TearLab (F) (I). J. A. Clayton: National Institutes of Health (E). M. Dogru: Otsuka Pharmaceuticals (F), Santen (F). H. Dua: Novartis (F); GlaxoSmithKline (I); Nicox, Théa, Allergan (C); NuVision (P); Alcon, Allergan, Bausch & Lomb, Nicox, Théa; NuVision (S). G. N. Foulks: TearLab (I); Eleven Biotherapeutics, Inc; Healios, Inc; Insite Pharmaceuticals, Inc; Kala, Inc; Lexitas, Inc; Parion, Inc; R-Tech Ueno, Inc; and Shire Pharmaceuticals, Inc. (C). J. A. P. Gomes: Allergan, Alcon, Bausch & Lomb/Valeant, Genon, Pfizer, MSD, Mundipharma (F); Allergan, Bausch & Lomb/Valeant (C). K. M. Hammitt: N. L. Jones: Advanced Vision Research, Alcon, Allergan, Contamac, CooperVision, Essilor, Inflamax, Johnson & Johnson Vision Care, Ocular Dynamics, Oculus, Safilens, TearLab, TearScience (F); Alcon, CooperVision, Johnson & Johnson Vision Care (C) (R). C-K. Joo: N. Z. Liu: Reilin Co. (C); Santen, Reilin, Alcon (R). J. J. Nichols: Johnson and Johnson Vision Care (F); Bruder Healthcare Company (F); Alcon (spouse), Allergan (spouse), Eleven Biotherapeutics (spouse), Kala, Oculus (spouse), Sarcode/Shire (spouse), TearScience (spouse), (F); Alcon (Spouse), Allergan (Spouse), Bausch & Lomb/Valeant (spouse), Eleven Biotherapeutics (spouse), Kala (Spouse), Insite Pharma (spouse), Parion (spouse), Sarcode/Shire (spouse), ScienceBased Health (spouse), Santen (spouse), Tearfilm Innovations (spouse), (C); Shire (R). K. K. Nichols: Allergan, Bruder Healthcare Company (spouse) Eleven Biotherapeutics, Johnson and Johnson Vision Care (spouse), Kala, Oculus, Sarcode/Shire, TearScience (F); Alcon, Allergan, Bausch & Lomb/Valeant, Eleven Biotherapeutics, Kala, Insite Pharma, Parion, Sarcode/Shire, ScienceBased Health, Santen, Tearfilm Innovations (C); Shire (Spouse) (R). G. D. Novack: Aldeyra, Allergan, Allysta, AmorChem, Aurinia Pharm, Auven, Bausch+ Lomb, CapaBio, Clementia Pharma, Eleven Biotherapeutics, I.com Medical, Kala Pharma, Lexitas Pharma, Lubris, MG Therapeutics, Oculeve, Oyster Point Pharma, Panoptica, Inc., Parion Sciences, Inc., Proteris Biotech, Inc., Senju Pharmaceutical Co., Ltd, Shire Pharmaceuticals, Inc., Sun Pharma, Sylentis, Theravance (C). V. Sangwan: N. F. Stapleton: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Stiltec (F); Nidek (C). K. Tsubota: Dai Nippon Insatsu, Echo Denki, JIN Co, Ltd., Kowa Co. Ltd., MediProduct, Inc., Molecular Physiology Chemistry Laboratory, Inc., Novartis Pharma K.K., Oryza Oil & Fat Chemical Co., Ltd., Santen Pharmaceutical Co., Ltd., Toshiba Materials Co., Ltd., WAKASA SEIKATSU Corp. (F); QOV, Inc., Tear Solutions, Tissue Tech Inc., Tsubota Laboratory, Inc. (I); Laboratoires Théa, Novaliq GmbH, SIFI, SpA (C); Functional Visual Acuity Meter, Moisture Glasses, Menisometry Strips, Vitamin D Ointment (P); AMO Japan K.K.; NIDEK Co. Ltd., Otsuka Pharmaceutical Co Ltd; Santen Pharmaceutical Co., Ltd. (R); Ocular Surface Research & Education Foundation (Board of Directors); Qualitas Inc., (Advisory Board); TearSolutions (Advisory Board); Yolia Health (Advisory Board); Metro Biotech (Advisory Board); Nobel Institute of Medical Science; (Spouse's company) (S). M. D. P. Willcox: Alcon Laboratories, Allergan, CooperVision, Johnson & Johnson Vision Care, Ophtecs (F); Allergan, Minomic International Pty., Ophtecs, Warm Contacts (C); Allergan, Ophtecs (R); Minomic International Pty., Ophtecs (S). J. S. Wolffsohn: Alcon, Bausch + Lomb, CooperVision, Eaglet Eye, European Union, Eyebag, EMPharma, EyeDocs, Innovate UK, Johnson & Johnson, Medmont, Théa, Optimec, Visioncare Research (F); British Contact Lens Association, University of Houston, Visioncare Research (C); Portable Aberrometer, Contrast Sensitivity Chart (P); Johnson & Johnson Vision Care (R).
PY - 2017/7
Y1 - 2017/7
UR - http://www.scopus.com/inward/record.url?scp=85025432066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025432066&partnerID=8YFLogxK
U2 - 10.1016/j.jtos.2017.05.005
DO - 10.1016/j.jtos.2017.05.005
M3 - Review article
C2 - 28736334
AN - SCOPUS:85025432066
VL - 15
SP - 269
EP - 275
JO - Ocular Surface
JF - Ocular Surface
SN - 1542-0124
IS - 3
ER -